Pages

Tampilkan postingan dengan label Global Campaign for Microbicides. Tampilkan semua postingan
Tampilkan postingan dengan label Global Campaign for Microbicides. Tampilkan semua postingan

Meet Gary Wolnitzek: The Last (But Not Least) of Our New Friendly Rectal Microbicide Advocates!

“First and foremost, as a gay man, and one who works at an organization focused on the LGBT community, it is extremely important to me that we develop ways that gay and bisexual men can protect themselves from HIV (and other STIs). Secondly, as an HIV advocate I feel it is important to create a robust and full toolbox that helps to prevent HIV infection and helps those living with HIV. Rectal Microbicides need to be one of the tools at our disposal.”

Gary is an IRMA advocate from Baltimore, Maryland. He is currently the Director of Gay, Lesbian, Bisexual, and Transgender Community Center of Baltimore (GLCCB). He loves conducting trainings in the community on a range of topics including advocacy planning, providing culturally competent care to the GLBT population and on topics related to new prevention technologies (NPT). He also enjoys spending time with friends at the pub, reading David Sedaris, watching “well-made” horror movies, and his cat, Aureliano.

Gary first became involved with IRMA while working at the Global Campaign for Microbicides (GCM). At this time he was well versed in preventative vaccine research and the research and trials surrounding vaginal microbicides, but he wasn’t as familiar with rectal microbicides. Shortly after starting at GCM he was introduced to people like Anna Forbes and Jim Pickett. He remembers a GCM meeting being co-hosted by the International Partnership for Microbicides (IPM) where this man kept chiming in with “What about rectal microbicides?!” Of course it was Jim, and Gary became inspired from that point on to learn more about rectal microbicides and involve himself with IRMA.

Gary tries to include vaginal and rectal microbicides in any talks he gives about HIV to the community. He believes knowledge is key, and a well informed base is necessary to move any work forward. He advises others doing HIV work to include microbicides in their agenda and points them to the IRMA website and blog for more information about them if needed. He also encourages IRMA members to become more involved on the listserv. He says that “by becoming more engaged in the conversations happening in this space then the more opportunities we have to gain new perspectives, find common ground on diverse issues, and develop new ideas.”

His advice for IRMA advocates combating stigma for their beliefs and work is to approach the individuals or organizations perpetuating the stigma with an open mind, listen to their arguments and opinions, and be prepared to create an informed and fact-based response. He hopes that this will bring about “some sort of common ground.” If this doesn’t work and the individual or organization is not willing to listen, he suggests reaching out to others that may be able to influence them- a method he calls “taking it to the streets!”

Read more bios on the IRMA website.


[If an item is not written by an IRMA member, it should not be construed that IRMA has taken a position on the article's content, whether in support or in opposition.]

Announcing the 2012 Omololu Falobi Award for Excellence in HIV Prevention Research Community Advocacy

Five years ago on October 5 2006, we lost our brother and colleague Omololu Falobi. Those who knew Omololu professionally will remember him, among many other things - as a talented journalist on HIV, as an activist for social justice, as an advocate for prevention research and as a son of Africa in his zeal to ensure Africans were taking ownership of their own HIV care and prevention.

Omololu founded the Journalists Against AIDS in Nigeria (JAAIDS), was an instrumental pioneer member of the Nigerian Treatment Access Movement (TAM), and co-founded the New HIV Vaccine & Microbicide Advocacy Society (NHMAS). He was tragically killed in 2006 in Lagos, Nigeria.

In 2008, in honour of Omololu’s memory and commitment to the field, The Omololu Falobi Award for Excellence in HIV Prevention Research Community Advocacy was established by the African Microbicides Advocacy Group (AMAG) and partners. The Award is presented to an individual nominated by their peers at the biennial International Microbicides Conferences. Lori Heise (USA) and Aylur Srikrishnan (India) were the 2008 recipients and Charles Shagi (Tanzania) the recipient in 2010.

In continuation of this tradition and to mark the fifth anniversary of Omololu’s death, we proudly announce the call for nominations of The Omololu Falobi Award for Excellence in HIV Prevention Research Community Advocacy 2012 to be awarded to a community advocate in recognition of their contribution to the HIV prevention research field through community advocacy.

The 2012 Award Planning Committee includes representatives from the African AIDS Vaccine Program (AAVP), AMAG, AVAC: Global Advocacy for HIV Prevention, the Global Campaign for Microbicides (GCM), International Rectal Microbicides Advocates (IRMA), JAAIDS, NHVMAS and TAM, with acknowledgment from the Omololu Falobi Foundation.

Nominations will be reviewed by a committee of stakeholders in the prevention research field and the selected individual will then be recognized and awarded at the Closing Ceremony of the International Microbicides 2012 Conference in Sydney, Australia in April 2012. We are pleased to work with the Microbicides 2012 Conference Planning Committee to present the Award next year.
A call for nominations and information on the selection process will be circulated later this month.

On behalf of the planning committee:
AAVP, AMAG, AVAC, GCM, IRMA, JAAIDS, NHVMAS, TAM

For more information:
Website: http://www.avac.org/ht/d/sp/i/4345/pid/4345
Email: amag_info@yahoo.com


[If an item is not written by an IRMA member, it should not be construed that IRMA has taken a position on the article's content, whether in support or in opposition.]

Don't Miss It! Recent Trends in Microbicide Formulations

via ScienceDirect, edited by David R. Friend

The most recent edition of Antiviral Research includes a series of review articles that cover every facet of microbicide development, evaluation and dissemination.


Editorial Board

Trends in microbicide formulations workshop

Preventing mucosal HIV transmission with topical microbicides: Challenges and opportunities

Preclinical evaluation of anti-HIV microbicide products: New models and biomarkers

Advances in development, scale-up and manufacturing of microbicide gels, films, and tablets

Advances in microbicide vaginal rings

Clinical evaluation of microbicide formulations

Combining prevention of HIV-1, other sexually transmitted infections and unintended pregnancies: Development of dual-protection technologies

Novel Approaches to Vaginal Delivery and Safety of Microbicides: Biopharmaceuticals, Nanoparticles, and Vaccines

Notes to Authors

[If an item is not written by an IRMA member, it should not be construed that IRMA has taken a position on the article's content, whether in support or in opposition.]